Psyence Biomedical (PBM) Operating Expenses (2024 - 2025)
Psyence Biomedical (PBM) recorded quarterly Operating Expenses of $574669.0 in Q3 2025, up 12.97% quarter-over-quarter from $508670.0 in Q3 2024, and up 12.97% on a YoY basis from $508670.0 in Q3 2024.
Psyence Biomedical (PBM) Operating Expenses (2024 - 2025) Analysis & Trends
Psyence Biomedical's Operating Expenses history runs 2 years deep, the most recent figure standing at $574669.0 for Q3 2025.
- In Q3 2025, Operating Expenses rose 12.97% year-over-year to $574669.0; the TTM figure through Sep 2025 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.6 million, up 2.88% from the prior year.
- Operating Expenses was $574669.0 for Q3 2025 at Psyence Biomedical, up from $508670.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $574669.0 in Q3 2025 to a low of $508670.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 2.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 574,669.00 |
| Sep 30, 2024 | 508,670.00 |